certican 0,1 mg dispergible tabletter
novartis healthcare a/s - everolimus - dispergible tabletter - 0,1 mg
certican 1 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 1 mg
aderolio 0,25 mg tabletter
sandoz a/s - everolimus - tabletter - 0,25 mg
aderolio 0,5 mg tabletter
sandoz a/s - everolimus - tabletter - 0,5 mg
aderolio 0,75 mg tabletter
sandoz a/s - everolimus - tabletter - 0,75 mg
aderolio 1 mg tabletter
sandoz a/s - everolimus - tabletter - 1 mg
kisplyx
eisai gmbh - lenvatinibmesilat - carcinom, nyrecelle - antineoplastiske midler - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
epidyolex
jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptika, - epidyolex er indiceret til brug som supplerende behandling af anfald forbundet med lennox gastaut syndrom (lgs) eller dravet syndrom (ds), i forbindelse med clobazam, for patienter 2 år og ældre.
odrik 0,5 mg kapsler, hårde
viatris aps - trandolapril - kapsler, hårde - 0,5 mg
trandolapril "2care4" 0,5 mg kapsler, hårde
2care4 aps - trandolapril - kapsler, hårde - 0,5 mg